Bajaj HealthCare
482.25
-21.65(-4.30%)
Market Cap₹1,591.50 Cr
PE Ratio37.15
IndustryHealthcare
Company Performance:
1D-4.30%
1M-9.72%
6M-23.72%
1Y+36.00%
5Y+32.87%
View Company Insightsright
Latest news about Bajaj HealthCare
Bajaj Healthcare Swings to Profit in Q4, Announces Dividend May 27, 2025
Bajaj Healthcare Ltd. reported a significant turnaround in Q4, posting a net profit of ₹111.80 crore compared to a loss of ₹299.20 crore in the previous year. Revenue increased to ₹154.00 crore, up 14.93% year-over-year. The company's board recommended a final dividend of ₹1.00 per equity share. Despite the strong yearly recovery, there was a slight decrease in profit from ₹117.20 crore in the previous quarter.
Bajaj Healthcare Reports Q4 Profit Turnaround and Announces Dividend May 26, 2025
Bajaj Healthcare Strengthens Financial Leadership with Appointment of Rohan Parekh as CFO Apr 10, 2025
Bajaj Healthcare Expands Manufacturing Capabilities with ₹10.85 Crore Acquisition of Genrx Pharmaceuticals Apr 07, 2025
More news about Bajaj HealthCare
03Apr 25
Bajaj Healthcare CFO Dayashankar Patel Resigns, Effective April 15
Bajaj Healthcare Limited (BHL) announced the resignation of CFO Dayashankar Patel, effective April 15, 2025, citing personal reasons. The company appreciated his services and confirmed no material reasons for the resignation beyond those stated. The announcement complies with SEBI regulations, and BHL is expected to manage the transition in financial leadership.
02Apr 25
Bajaj Healthcare CFO Dayashankar Patel Steps Down, Citing Personal Reasons
Bajaj Healthcare Limited announced that its Chief Financial Officer (CFO), Dayashankar Patel, has resigned due to personal reasons. Patel will be relieved from his duties as CFO and Key Managerial Personnel after April 15, 2025. The company expressed appreciation for Patel's services and confirmed no material reasons for the resignation beyond those stated. The announcement was made on April 2, 2025, allowing for a brief transition period. Bajaj Healthcare has complied with SEBI regulations by disclosing the change to relevant stock exchanges. No successor has been announced yet.
Bajaj HealthCare
482.25
-21.65
(-4.30%)
1 Year Returns:+36.00%
Industry Peers
Sun Pharmaceutical
1,667.20
(-0.51%)
Divis Laboratories
6,856.50
(+0.69%)
Cipla
1,515.70
(+0.65%)
Torrent Pharmaceuticals
3,416.70
(+0.25%)
Dr Reddys Laboratories
1,276.80
(-0.51%)
Zydus Life Science
1,002.50
(+1.27%)
Mankind Pharma
2,287.00
(-1.41%)
Lupin
1,960.90
(+1.18%)
Abbott
34,665.00
(-2.82%)
Aurobindo Pharma
1,132.50
(-0.20%)